Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/25/2025 | $65.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 4/7/2025 | $56.00 → $33.00 | Equal-Weight → Underweight | Morgan Stanley |
| 1/3/2025 | Outperform → Peer Perform | Wolfe Research | |
| 12/20/2024 | $65.00 → $57.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 12/9/2024 | $60.00 → $63.00 | Overweight → Equal-Weight | Morgan Stanley |
| 9/12/2024 | $51.00 | Equal Weight | Wells Fargo |
| 1/29/2024 | $51.00 | Outperform | Keefe Bruyette |
| 1/3/2024 | $42.00 | Peer Perform → Outperform | Wolfe Research |
4 - Lazard, Inc. (0001311370) (Issuer)
4 - Lazard, Inc. (0001311370) (Issuer)
4 - Lazard, Inc. (0001311370) (Issuer)
144 - Lazard, Inc. (0001311370) (Subject)
8-K - Lazard, Inc. (0001311370) (Filer)
8-K - Lazard, Inc. (0001311370) (Filer)
Keefe Bruyette upgraded Lazard from Mkt Perform to Outperform and set a new price target of $65.00
Morgan Stanley downgraded Lazard from Equal-Weight to Underweight and set a new price target of $33.00 from $56.00 previously
Wolfe Research downgraded Lazard from Outperform to Peer Perform
Lazard, Inc. (NYSE:LAZ) today announced the appointment of Cyrille Cotte as Managing Director and Head of Insurance for its European Financial Institutions Group (FIG), based in London and working across Europe with regional Co-Heads of Financial Services Coverage Nick Millar and Corso Bavagnoli. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930678445/en/Cyrille Cotte Cyrille joins Lazard from Evercore, where he was a Partner and Senior Managing Director in the European Financial Institutions Group. Over his career, he has focused on advising a broad range of insurers and other financial services firms on mergers, acquisitio
Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on October 22, 2025, to shareholders of record on October 10, 2025. The ex-dividend date is October 10, 2025. The Fund will pay a previously declared distribution today, September 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income,
Lazard announced today that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, advising on transactions across diversified biopharmaceuticals. "We are thrilled to welcome Geoffrey to Lazard," said David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare. "His deep understanding of the biopharmaceutical industry's strategic and financial landscape, coupled with his ability to help companies translate scientific innovation into actionable business strategies, will empower our clients to strengthen their competitive positions, capitalize on growth opportunities, and build resilient companies in a challenging geopolitical an
Lazard, Inc. (NYSE:LAZ) today announced the appointment of Cyrille Cotte as Managing Director and Head of Insurance for its European Financial Institutions Group (FIG), based in London and working across Europe with regional Co-Heads of Financial Services Coverage Nick Millar and Corso Bavagnoli. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930678445/en/Cyrille Cotte Cyrille joins Lazard from Evercore, where he was a Partner and Senior Managing Director in the European Financial Institutions Group. Over his career, he has focused on advising a broad range of insurers and other financial services firms on mergers, acquisitio
Lazard announced today that Dr. Geoffrey Porges has joined the firm as Managing Director in the Healthcare Advisory Group, advising on transactions across diversified biopharmaceuticals. "We are thrilled to welcome Geoffrey to Lazard," said David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare. "His deep understanding of the biopharmaceutical industry's strategic and financial landscape, coupled with his ability to help companies translate scientific innovation into actionable business strategies, will empower our clients to strengthen their competitive positions, capitalize on growth opportunities, and build resilient companies in a challenging geopolitical an
Succeeds Evan Russo who transitions into advisory role following two decades of leadership at the firm Lazard, Inc. (NYSE:LAZ) today announced Christopher Hogbin has been appointed CEO of Lazard Asset Management, effective December 2025. Mr. Hogbin has 30 years of professional experience, including 20 years at AllianceBernstein where he most recently served as Global Head of Investments and a member of its Executive Leadership Team. An accomplished global business and investment leader, Mr. Hogbin played a pivotal role in expanding and diversifying AllianceBernstein's investment capabilities across public and private markets, elevating its research function, and delivering exceptional out
Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on October 22, 2025, to shareholders of record on October 10, 2025. The ex-dividend date is October 10, 2025. The Fund will pay a previously declared distribution today, September 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment income,
Lazard Global Total Return and Income Fund, Inc. (the "Fund") (NYSE:LGI) is confirming today, pursuant to its Managed Distribution Policy, as previously authorized by its Board of Directors, a monthly distribution of $0.14646 per share on the Fund's outstanding common stock. The distribution is payable on September 22, 2025, to shareholders of record on September 11, 2025. The ex-dividend date is September 11, 2025. The Fund will pay a previously declared distribution today, August 22, 2025. The following table sets forth the estimated amounts of the current distribution and the cumulative distributions paid, including today's distribution, from the following sources: net investment incom
Financial Advisory reported record adjusted net revenue for the second quarter up 20% year over year and driven by robust activity in Europe Asset Management reported positive net flows in the second quarter and AUM of $248 billion as of June 30, 2025 Financial Advisory hired 14 Managing Directors year to date, underscoring success in attracting world-class talent to support long-term growth Lazard, Inc. (NYSE:LAZ) today reported net revenue of $796 million and adjusted net revenue1 of $770 million for the quarter ended June 30, 2025. For the first half of 2025, Lazard reported net revenue of $1,444 million and adjusted net revenue1 of $1,413 million. On both a U.S. GAAP and
SC 13G - Lazard, Inc. (0001311370) (Subject)
SC 13G/A - Lazard, Inc. (0001311370) (Subject)
SC 13G/A - Lazard, Inc. (0001311370) (Subject)